Elevated Aβ and Apolipoprotein E in AβPP Transgenic Mice and Its Relationship to Amyloid Accumulation in Alzheimer’s Disease

Molecular Medicine

Volumn 6, Issue 5, 2000, Pages 430-439

  Kuo, Yu Min ^a   Crawford, Fiona ^b   Mullan, Michael ^b   Kokjohn, Tyler A ^c   Emmerling, Mark R ^d   Weller, Roy O ^e   Roher, Alex E ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

^d PFIZER INC   (United States)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

A PP Transgenic Mice; Brain apoE; Brain Cholesterol; Cerebral Amyloid Angiopathy (CAA); Tg2576 Mice

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

AGING; ALZHEIMER DISEASE; ANIMAL; ARTICLE; BRAIN; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LEARNING DISORDER; MEMORY DISORDER; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; BRAIN; HUMANS; LEARNING DISORDERS; MEMORY DISORDERS; MICE; MICE, TRANSGENIC;

MLCS; MLOWN;

EID: 0034183020     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03401785     Document Type: Article

References (56)

1. V.M. Lee B.J. Balin L.J. Otvos J.Q. Trojanowski A68: a major subunit of paired helical filaments and derivatized forms of normal Tau Science 1991 251 675 678 10.1126/science.1899488 1:CAS:528:DyaK3MXhsVSqs7k%3D 1899488
2. W.J. Goux S. Rodriguez D.R. Sparkman Analysis of the core components of Alzheimer paired helical filaments. A gas chromatography/mass spectrometry characterization of fatty acids, carbohydrates and long-chain bases FEBS Lett. 1995 366 81 85 10.1016/0014-5793(95)00486-S 1:CAS:528:DyaK2MXms1Cgtrk%3D 7789523
3. C.L. Masters G. Simms N.A. Weinman G. Multhaup B.L. McDonald K. Beyreuther Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U.S.A. 1985 82 4245 4249 10.1073/pnas.82.12.4245 1:CAS:528:DyaL2MXktlGltr0%3D 3159021 397973
4. A.E. Roher J.D. Lowenson S. Clarke et al. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer’s disease J. Biol. Chem. 1993 268 3072 3083 8428986 1:CAS:528:DyaK3sXhsVGjsb0%3D
5. A.E. Roher J.D. Lowenson S. Clarke et al. β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 1993 90 10836 10840 10.1073/pnas.90.22.10836 1:CAS:528:DyaK2cXltFOjtQ%3D%3D 8248178 47873
6. N.C. Alonzo B.T. Hyman G.W. Rebeck S.M. Greenberg Progression of cerebral amyloid angiopathy: accumulation of amyloid-β40 in affected vessels J. Neuropathol. Exp. Neurol. 1998 57 353 359 10.1097/00005072-199804000-00008 1:STN:280:DyaK1c3mtVymtA%3D%3D 9600229
7. M.R. Emmerling S. Gracon A.E. Roher S. Gauthier Towards a unifying hypothesis of Alzheimer’s disease pathogenesis and pathophysiology Clinical Diagnosis and Management of Alzheimer’s Disease 1999 London Martin Dunitz 33 53
8. H. Funato M. Yoshimura K. Kusui et al. Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer’s disease Am. J. Pathol. 1998 152 1633 1640 9626067 1858449 1:CAS:528:DyaK1cXktVSrsr0%3D
9. K.H. Weisgraber R.W. Mahley Human apolipoprotein E: the Alzheimer’s disease connection FASEB J. 1996 10 1485 1494 10.1096/fasebj.10.13.8940294 1:CAS:528:DyaK28XntFWkurg%3D 8940294
10. E.H. Corder A.M. Saunders W.J. Strittmatter et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families Science 1993 261 921 923 10.1126/science.8346443 1:CAS:528:DyaK3sXmtVWjur8%3D 8346443
11. M.R. Meyer J.T. Tschanz M.C. Norton et al. APOE genotype predicts when—not whether— one is predisposed to develop Alzheimer disease Nat. Genet. 1998 19 321 322 10.1038/1206 1:CAS:528:DyaK1cXlt1Cju7o%3D 9697689
12. D.E. Schmechel A.M. Saunders W.J. Strittmatter et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 1993 90 9649 9653 10.1073/pnas.90.20.9649 1:CAS:528:DyaK2cXmtFel 8415756 47627
13. S.M. Greenberg G.W. Rebeck J.P. Vonsattel T. Gomez-Isla B.T. Hyman Apolipoprotein Ee4 and cerebral hemorrhage associated with amyloid angiopathy Ann. Neurol. 1995 38 254 259 10.1002/ana.410380219 1:CAS:528:DyaK2MXns1Kgu7o%3D 7654074
14. K. Hsiao P. Chapman S. Nilsen et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice Science 1996 274 99 102 10.1126/science.274.5284.99 1:CAS:528:DyaK28XmtVyns7c%3D 8810256
15. Kuo YM, Kokjohn TA, Watson MD, et al. (In press) Elevated A β 42 in skeletal muscle of Alzheimer disease patients suggest peripheral alterations of APP metabolism. Am. J. Pathol 156: 797–805.
16. P.D. Mehta A.J. Dalton S.P. Mehta K.S. Kim E.A. Sersen H.M. Wisniewski Increased plasma amyloid β protein 1–42 levels in Down syndrome Neurosci. Lett. 1998 241 13 16 10.1016/S0304-3940(97)00966-X 1:CAS:528:DyaK1cXntlWhtw%3D%3D 9502204
17. L. Holmquist K. Carlson Selective extraction of human serum very low density apolipoproteins with organic solvents Biochim. Biophys. Acta 1977 493 400 409 10.1016/0005-2795(77)90196-9 1:CAS:528:DyaE2sXltFCit7s%3D 196662
18. P.J. Dolphin Organic extraction and preparative isoelectric focussing of rat serum apolipoproteins FEBS Lett. 1980 117 252 258 10.1016/0014-5793(80)80956-2 1:CAS:528:DyaL3cXmtFOgurY%3D 7409171
19. P.J. Dolphin L. Wong D. Rubinstein A comparison of some immunological characteristics of very low density lipoproteins of normal and hypercholesterolemic rat sera Can. J. Biochem. 1978 56 673 683 10.1139/o78-101 1:CAS:528:DyaE1cXkvVygtr0%3D 208733
20. J. Folch M. Lees G.H.S. Stanley A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 1956 226 497 509
21. D.S. Howland S.P. Trusko M.J. Savage et al. Modulation of secreted β-amyloid precursor protein and amyloid β-peptide in brain by cholesterol J. Biol. Chem. 1998 273 16576 16582 10.1074/jbc.273.26.16576 1:CAS:528:DyaK1cXkt1GgtLk%3D 9632729
22. K.R. Bales T. Verina R.C. Dodel et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition Nat. Genet. 1997 17 263 264 10.1038/ng1197-263 1:CAS:528:DyaK2sXntVShsbk%3D 9354781
23. K.R. Bales T. Verina D.J. Cummins et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer’s disease Proc. Natl. Acad. Sci. U.S.A. 1999 96 15233 15238 10.1073/pnas.96.26.15233 1:CAS:528:DC%2BD3cXhtFejug%3D%3D 10611368 24803
24. A.D. Roses Apolipoprotein E alleles as risk factors in Alzheimer’s disease Annu. Rev. Med. 1996 47 387 400 10.1146/annurev.med.47.1.387 1:CAS:528:DyaK28XitlSntLs%3D 8712790
25. J. Poirier Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer’s disease J. Psychiatry Neurosci. 1999 24 147 153 10212558 1188996 1:STN:280:DyaK1M3ivFShug%3D%3D
26. M.J. LaDu J.R. Lukens C.A. Reardon G.S. Getz Association of human, rat, and rabbit apolipoprotein E with β-amyloid J. Neurosci. Res. 1997 49 9 18 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H 1:CAS:528:DyaK2sXkt1ektLc%3D 9211985
27. Walker LC, Pahnke J, Madauss M, et al. (In press) Apolipoprotein E4 promotes the early deposition of A β 42 and then A β 40 in the elderly. Acta Neuropathol.
28. E.J. Mufson E.Y. Chen E.J. Cochran L.A. Beckett D.A. Bennett J.H. Kordower Entorhinal cortex β-amyloid load in individuals with mild cognitive impairment Exp. Neurol. 1999 158 469 490 10.1006/exnr.1999.7086 1:CAS:528:DyaK1MXksFanu7c%3D 10415154
29. J.L. Price J.C. Morris Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease Ann. Neurol. 1999 45 358 368 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X 1:STN:280:DyaK1M7ntValtQ%3D%3D 10072051
30. D.I. Graham S.M. Gentleman J.A. Nicoll et al. Is there a genetic basis for the deposition of β-amyloid after fatal head injury? Cell Mol. Neurobiol. 1999 19 19 30 10.1023/A:1006937205905 1:CAS:528:DyaK1MXhsFSit7k%3D 10079962
31. B.D. Jordan N.R. Relkin L.D. Ravdin A.R. Jacobs A. Bennett S. Gandy Apolipoprotein E epsilon 4 associated with chronic traumatic brain injury in boxing JAMA 1997 278 136 140 10.1001/jama.1997.03550020068040 1:STN:280:DyaK2szlslWkug%3D%3D 9214529
32. D.B. Carter E. Dunn D.D. McKinley et al. Increased levels of apolipoprotein E4 accelerates amyloid deposition in APPsw transgenic mouse brain Soc. Neurosci. Abstr. 1999 25 1348 part 2
33. M.J. LaDu M.T. Falduto A.M. Manelli C.A. Reardon G.S. Getz D.E. Frail Isoform-specific binding of apolipoprotein E to β-amyloid J. Biol. Chem. 1994 269 23403 23406 8089103 1:CAS:528:DyaK2cXmtVagtbk%3D
34. Z. Zhou J.D. Smith P. Greengard S. Gandy Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ϵ 3 but not type ϵ 4 isoform of native apolipoprotein E Mol. Med. 1996 2 175 180 10.1007/BF03401614 1:CAS:528:DyaK28XjtFKht7c%3D 8726460 2230120
35. S. Aleshkov C.R. Abraham V.I. Zannis Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide β (1–40). Relevance to Alzheimer’s disease Biochemistry 1997 36 10571 10580 10.1021/bi9626362 1:CAS:528:DyaK2sXltFSjtLo%3D 9265639
36. S.B. Aleshkov X. Li S.N. Lavrentiadou V.I. Zannis Contribution of cysteine 158, the glyco-sylation site threonine 194, the amino- and car-boxy-terminal domains of apolipoprotein E in the binding to amyloid peptide β (1–40) Biochemistry 1999 38 8918 8925 10.1021/bi982002q 1:CAS:528:DyaK1MXjvVyqsLs%3D 10413465
37. U. Beffert N. Aumont D. Dea S. Lussier-Cacan J. Davignon J. Poirier Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures Brain Res. Mol. Brain Res. 1999 68 181 185 10.1016/S0169-328X(99)00073-X 1:CAS:528:DyaK1MXjs1eiu78%3D 10320795
38. D.S. Yang D.H. Small U. Seydel et al. Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner Neuroscience 1999 90 1217 1226 10.1016/S0306-4522(98)00561-2 1:CAS:528:DyaK1MXisFKitL0%3D 10338292
39. E.M. Castano F. Prelli T. Wisniewski et al. Fibrillogenesis in Alzheimer’s disease of amyloid β peptides and apolipoprotein E Biochem. J. 1995 306 599 604 10.1042/bj3060599 1:CAS:528:DyaK2MXkt1Khtbw%3D 7534068 1136559
40. K.C. Evans E.P. Berger C.G. Cho K.H. Weisgraber P.T.J. Lansbury Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogene-sis and treatment of Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 1995 92 763 767 10.1073/pnas.92.3.763 1:CAS:528:DyaK2MXjsVKitbg%3D 7846048 42700
41. D.A. Sanan K.H. Weisgraber S.J. Russell et al. Apolipoprotein E associates with β amyloid peptide of Alzheimer’s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 J. Clin. Invest. 1994 94 860 869 10.1172/JCI117407 1:CAS:528:DyaK2cXltlWmtLY%3D 8040342 296168
42. T. Wisniewski E.M. Castano A. Golabek T. Vogel B. Frangione Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro Am. J. Pathol. 1994 145 1030 1035 7977635 1887417 1:CAS:528:DyaK2MXit1WksLs%3D
43. C. Russo G. Angelini D. Dapino et al. Opposite roles of apolipoprotein E in normal brains and in Alzheimer’s disease Proc. Natl. Acad. Sci. U.S.A. 1998 95 15598 15602 10.1073/pnas.95.26.15598 1:CAS:528:DyaK1MXhvFejtw%3D%3D 9861015 28089
44. T. Wyss-Coray E. Masliah M. Mallory et al. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer’s disease Nature 1997 389 603 606 10.1038/39321 1:CAS:528:DyaK2sXmslWgu70%3D 9335500
45. C.L. Martel J.B. Mackic E. Matsubara et al. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer’s amyloid β J. Neurochem. 1997 69 1995 2004 10.1046/j.1471-4159.1997.69051995.x 1:CAS:528:DyaK2sXmvVKksbc%3D 9349544
46. B.V. Zlokovic C.L. Martel J.B. Mackic et al. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer’s amyloid β Biochem. Biophys. Res. Commun. 1994 205 1431 1437 10.1006/bbrc.1994.2825 1:CAS:528:DyaK2MXivVWlurs%3D 7802679
47. R.W. Mahley Z.S. Ji Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E J. Lipid Res. 1999 40 1 16 9869645 1:CAS:528:DyaK1MXjsl2hsQ%3D%3D
48. A.D. Snow R. Sekiguchi D. Nochlin et al. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain Neuron 1994 12 219 234 10.1016/0896-6273(94)90165-1 1:CAS:528:DyaK2cXivFGrsLY%3D 8292358
49. J. Naslund J. Thyberg L.O. Tjernberg et al. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer’s disease brain Neuron 1995 15 219 228 10.1016/0896-6273(95)90079-9 1:STN:280:DyaK2MzksVOktA%3D%3D 7619525
50. L. Paka Y. Kako J.C. Obunike S. Pillarisetti Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e J. Biol. Chem. 1999 274 4816 4823 10.1074/jbc.274.8.4816 1:CAS:528:DyaK1MXhsFSlsr0%3D 9988721
51. G.M. Castillo W. Lukito T.N. Wight A.D. Snow The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation J. Neurochem. 1999 72 1681 1687 10.1046/j.1471-4159.1999.721681.x 1:CAS:528:DyaK1MXitFCktro%3D 10098877
52. P.F. Chapman G.L. White M.W. Jones et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice Nat. Neurosci. 1999 2 271 276 10.1038/6374 1:CAS:528:DyaK1MXhsl2gu7k%3D 10195221
53. R. Mayeux M.X. Tang D.M. Jacobs et al. Plasma amyloid β-peptide 1–42 and incipient Alzheimer’s disease Ann. Neurol. 1999 46 412 416 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A 1:CAS:528:DyaK1MXmtF2qt7w%3D 10482274
54. C.R.J. Jack R.C. Petersen Y.C. Xu et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Neurology 1999 52 1397 1403 10.1212/WNL.52.7.1397 10227624 2730146
55. D.L. Sparks Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer’s disease? Ann. N. Y. Acad. Sci. 1997 826 128 146 10.1111/j.1749-6632.1997.tb48466.x 1:CAS:528:DyaK2sXmvFylsbY%3D 9329686
56. G.E. Swan C. DeCarli B.L. Miller et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology Neurology 1998 51 986 993 10.1212/WNL.51.4.986 1:STN:280:DyaK1cvlt1Okug%3D%3D 9781518